---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-072612"
form_type: "8-K"
ticker: "LITS"
cik: "0001262104"
company_name: "Lite Strategy, Inc."
filed_at: "2023-12-22T23:59:59+00:00"
generated_at: "2026-06-07T07:46:40.377481+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# MEI Pharma adopts Sixth Amended and Restated Bylaws effective December 18, 2023

## Summary
- Board designated at eight directors; amendments conform to revised DGCL.
- Changes include updated meeting notice rules, adjourned meetings, record date.
- Board may now designate any person (not just officers) to chair stockholder meetings.
- Director removal standard aligned with DGCL and Certificate of Incorporation.
- Administrative updates: gender-neutral terms, waiver by electronic transmission.

## SEC filing metadata
- accession: 0000950170-23-072612
- form_type: 8-K
- ticker: LITS
- cik: 0001262104
- company_name: Lite Strategy, Inc.
- filed_at: 2023-12-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1262104/000095017023072612/0000950170-23-072612-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1262104/000095017023072612/meip-20231218.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-072612
- JSON: https://secwatch.observer/filing/0000950170-23-072612.json
- Plain text: https://secwatch.observer/filing/0000950170-23-072612.txt

## Key facts
- Governance Changes
  Lite Strategy, Inc.: Amended and restated bylaws to align with DGCL, update meeting procedures, director count, removal standard, and gender-neutral terms (effective 2023-12-18).
  - Change: bylaw amendment
  - Effective: 2023-12-18
  source text: On December 18, 2023, the Board of Directors (the Board) of MEI Pharma, Inc. (the Company) approved the Sixth Amended and Restated Bylaws of the Company (the Sixth A&R Bylaws), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1262104/000095017023072612/0000950170-23-072612-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.